<?xml version="1.0" encoding="UTF-8"?>
<p id="par0240">Ouabain (
 <bold>96</bold>) and bufalin (
 <bold>97</bold>) (
 <xref rid="fig0065" ref-type="fig">Fig. 13</xref>) can inhibit MERS-CoV entry by blocking clathrin-mediated endocytosis 
 <xref rid="bib0765" ref-type="bibr">[153]</xref>. Dihydrotanshinone (
 <bold>98</bold>, 
 <xref rid="fig0065" ref-type="fig">Fig. 13</xref>), a lipophilic compound, showed a decimal reduction at 0.5 μg/mL and excellent antiviral effects at ≥2 μg/mL with a reduction in titer from 6.5 Log to 1.8 Log TCID
 <sub>50</sub>/mL by using a pseudovirus expressing MERS-CoV spike protein 
 <xref rid="bib0770" ref-type="bibr">[154]</xref>. During the biosynthesis of MERS-CoV S protein, the furin inhibitor decanoyl-RVKR-chloromethylketone (dec-RVKR-CMK, 
 <bold>99</bold>, 
 <xref rid="fig0065" ref-type="fig">Fig. 13</xref>) at 75 μM can lead to a decrease of the 85-kDa cleaved product in MERS-CoV S wt and S2′ mutant 
 <xref rid="bib0775" ref-type="bibr">[155]</xref>.
</p>
